NEW YORK STOCK EXCHANGE, INC. · PBH
-3.79% · -$1.81 · Vol 504.0K
Market closed · last close 4:00 PM ET · price as of 19:00:00 ET
Prestige Consumer Healthcare Inc

Prestige Consumer Healthcare Inc

Pharmaceuticals
$45.92
Card
Relationship Map

Follow $PBH

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $PBH by email

Veridion Score

BETAHIGH CONF · 6 of 6 factors measuredMethodology
PBH
Prestige Consumer Healthcare Inc
Wed Sep 23 · market closed · Markets closed · resumes Thu 9:30 ET
Upper range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

73/ 100
Veridion Score
Upper range · HIGH confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Confidence: HIGH · 6 of 6 factors measured · Wed Sep 23 · market closed · Markets closed · resumes Thu 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is PBH moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading PBH catalysts
About Prestige Consumer Healthcare Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2005
Employees
890
Country
US

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$47.45
Day high
$47.45
Day low
$45.91
Previous close
$47.73
52W high
$70.21
-34.60% from high
52W low
$44.97
4% of range
Market cap
$2.3B
P/E
13.55×
EPS
$3.39
Beta
-0.39
Shares out
47.4M
Volume
504K
0.93× rel vol
Avg volume
542K
VWAP
$46.35
Price history computed in-house
1W
-1.18%
1M
-10.75%
3M
-7.06%
1Y
-27.40%
YTD
-25.56%
SMA 50 $50.39 · below
SMA 200 $56.07 · below
52W position 4%

PBH overview

Loading financial statements
Loading PBH Form 4 filings
Public disclosures

Congress activity in PBH

Federal contracts

PBH contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for PBH in this window.
Lobbying spend

PBH lobbying filings, year to date.

Registered lobbying filings matched to Prestige Consumer Healthcare Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for PBH in this window.
Loading news for PBH
Analyst ratings
Sovereign unlock shows live analyst consensus for PBH.
Options
Sovereign unlock shows live options positioning for PBH.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.